📰 Outcomes Phase News
Outcomes Phase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Outcomes Phase. Real-time updates on events, politics, business and more.
December 1, 2023
AstraZeneca on Friday said it would discontinue two late-stage trials looking at the potential benefits of its drug Lokelma in the management of hyperkalaemia across the cardiorenal spectrum. ...
December 1, 2023
AstraZeneca discontinues STABILIZE-CKD and DIALIZE-Outcomes Phase III trials
December 1, 2023
A2725v FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Issuer Pursuant to Rule 13a-16 or...
December 1, 2023
FTSE 100 up 43 points at 7,497 House prices rise 0.2% in November Miners jump on positive China data 13:08pm: Pfizer shares dip on obesity pill setback A...
December 1, 2023
AstraZeneca Plc AZN discontinued the STABILIZE-CKD and DIALIZE-Outcomes Phase 3 evidence trials for Lokelma (sodium zirconium cyclosilicate). The decision was…
December 1, 2023
FTSE 100 closes up 76 points at 7,529 House prices rise 0.2% in November Miners jump on positive China data 4.49pm: FTSE zooms higher at the close Londons...
December 1, 2023
AstraZeneca Plc (NASDAQ: AZN) discontinued the STABILIZE-
December 1, 2023
FTSE 100 closes up 76 points at 7,529 House prices rise 0.2% in November Miners jump on positive China data 4.49pm: FTSE zooms higher at the close Londons...